Abstract
Integrated human genetics and molecular/developmental biology studies have revealed that truncus arteriosus is highly associated with 22q11.2 deletion syndrome. Other congenital malformation syndromes and variants in genes encoding TBX, GATA, and NKX transcription factors and some signaling proteins have also been reported as its etiology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yamagishi H, Fukuda K. Truncus arteriosus. In: Lang F, editor. Encyclopedia of molecular mechanisms of disease. Springer; 2009. Version: print (book), LXXXVI, 2270 p. 646 illus. In 3 volumes, not available separately. Hardcover ISBN: 978-3-540-67136-7.
Ferencz C, Correa-Villasenor A, Loffredo CA, editors. Genetic and environmental risk factors of major cardiovascular malformations: the Baltimore-Washington infant study: 1981–1989. Armonk: Futura Publishing Co; 1997.
Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics. Circulation. 2007;115:2995–3014.
Kodo K, Yamagishi H. A decade of advances in the molecular embryology and genetics underlying congenital heart defects. Circ J. 2011;75:2296–304.
Yamagishi H. The 22q11.2 deletion syndrome. Keio J Med. 2002;51:77–88.
Yamagishi H, Srivastava D. Unraveling the genetic and developmental mysteries of 22q11 deletion syndrome. Trends Mol Med. 2003;9:383–9.
Nora JJ, Nora AH. Update on counseling the family with a first degree relative with a congenital heart defect. Am J Med Genet. 1988;29:137–42.
Pierpont MEM, Gobel JW, Moller JH, et al. Cardiac malformations in relatives of children with truncus arteriosus or interruption of the aortic arch. Am J Cardiol. 1988;61:423–7.
Lindsay EA, Baldini A. Congenital heart defects and 22q11 deletions: which genes count? Mol Med Today. 1998;4:350–7.
Goldmuntz E, Clark BJ, Mitchell LE, et al. Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol. 1988;32:492–8.
Maeda J, Yamagishi H, Matsuoka R, et al. Frequent association of 22q11.2 deletion with tetralogy of Fallot. Am J Med Genet. 2000;92:269–72.
Mlynarski EE, Xie M, Taylor D, et al. Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome. Hum Genet. 2016;135:273–85.
Zhao Y, Diacou A, Johnston HR, et al. Complete sequence of the 22q11.2 allele in 1,053 subjects with 22q11.2 deletion syndrome reveals modifiers of Conotruncal heart defects. Am J Hum Genet. 2020;106:26–40.
Momma K, Ando M, Matsuoka R. Truncus arteriosus communis associated with chromosome 22q11 deletion. J Am Coll Cardiol. 1997;30:1067–71.
Lalani SR, Safiullah AM, Fernbach SD, et al. Spectrum of CHD7 variants in 110 individuals with CHARGE syndrome and genotype-phenotype correlation. Am J Hum Genet. 2006;78:303–14.
Lalani SR, Safiullah AM, Molinari LM, et al. SEMA3E variant in a patient with CHARGE syndrome. J Med Genet. 2004;41:e94.
Garcia-Barcelo M-M, Wong KK, Lui VC, et al. Identification of a HOXD13 variant in a VACTERL patient. Am J Med Genet. 2008;146A:3181–5.
Daw SCM, Taylor C, Kraman M, et al. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat Genet. 1996;13:458–61.
Yamagishi H, Garg V, Matsuoka R, et al. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science. 1999;283:1158–61.
Kunte A, Ivey C, Yamagishi C, et al. A common cis-acting sequence in the DiGeorge critical region regulates bi-directional transcription of UFD1L and CDC45L. Mech Dev. 2001;108:81–92.
Verloove-Vanhorick SP, Brubakk AM, Ruys JH. Extensive congenital malformations in two siblings: maternal pre-diabetes or a new syndrome? Acta Paediatr Scand. 1981;70:767–9.
Lewin SO, Opitz JM. Fibular a/hypoplasia: review and documentation of the fibular developmental field. Am J Med Genet. 1986;25(suppl 2):215–38.
Ellis IH, Yale C, Thomas R, et al. Three sibs with microcephaly, congenital heart disease, lung segmentation defects and unilateral absent kidney: a new recessive multiple congenital anomaly (MCA) syndrome? Clin Dysmorphol. 1996;5:129–34.
Frank V, Habbig S, Bartram MP, et al. Variants in NEK8 link multiple organ dysplasia with altered hippo signaling and increased c-MYC expression. Hum Mol Genet. 2013;22:2177–85.
Lindsay EA. Chromosome microdeletions: dissecting del22q11 syndrome. Nat Rev Genet. 2001;2:858–68.
Lindsay EA, Vitelli F, Su H, et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice. Nature. 2001;410:97–101.
Merscher S, Funke B, Epstein JA, et al. TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell. 2001;104:619–29.
Garg V, Yamagishi C, Hu T, et al. Tbx1, a DiGeorge syndrome candidate gene, is regulated by sonic hedgehog during pharyngeal arch development. Dev Biol. 2001;235:62–73.
Yamagishi H, Maeda J, Hu T, et al. Tbx1 is regulated by tissue-specific forkhead proteins through a common sonic hedgehog-responsive enhancer. Genes Dev. 2003;17:269–81.
Xu H, Morishima M, Wylie JN, et al. Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development. 2004;131:3217–27.
Maeda J, Yamagishi H, McAnally J, et al. Tbx1 is regulated by forkhead proteins in the secondary heart field. Dev Dyn. 2006;235:701–10.
Yagi H, Furutani Y, Hamada H, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362:1366–73.
Huang RT, Wang J, Xue S, et al. TBX20 loss-of-function mutation responsible for familial tetralogy of Fallot or sporadic persistent truncus arteriosus. Int J Med Sci. 2017;14:323–32.
Brewer A, Pizzey J. GATA factors in vertebrate heart development and disease. Expert Rev Mol Med. 2006;8:1–20.
Kodo K, Nishizawa T, Furutani M, et al. GATA6 variants cause human cardiac outflow tract defects by disrupting semaphoring-plexin signaling. Proc Natl Acad Sci U S A. 2009;106:13933–8.
Ta-Shma A, Pierri CL, Stepensky P, et al. Isolated truncus arteriosus associated with a variant in the plexin-D1 gene. Am J Med Genet A. 2013;161A:3115–20.
Kodo K, Shibata S, Miyagawa-Tomita S, et al. Regulation of Sema3c and the interaction between cardiac neural crest and second heart field during outflow tract development. Sci Rep. 2017;7:6771.
Kodo K, Nishizawa T, Furutani M, et al. Genetic analysis of essential cardiac transcription factors in 256 patients with non-syndromic congenital heart defects. Circ J. 2012;76:1703–11.
Maitra M, Koenig SN, Srivastava D, et al. Identification of GATA6 sequence variants in patients with congenital heart defects. Pediatr Res. 2010;68:281–5.
Lin X, Huo Z, Liu X, et al. A novel GATA6 variant in patients with tetralogy of Fallot or atrial septal defect. J Hum Genet. 2010;55:662–7.
Wang X, Ji W, Wang J, et al. Identification of two novel GATA6 mutations in patients with nonsyndromic conotruncal heart defects. Mol Med Rep. 2014;10:743–8.
Zhang E, Hong N, Chen S, et al. Targeted sequencing identifies novel GATA6 variants in a large cohort of patients with conotruncal heart defects. Gene. 2018;641:341–8.
Raghuram N, Marwaha A, Greer MC, et al. Congenital hypothyroidism, cardiac defects, and pancreatic agenesis in an infant with GATA6 mutation. Am J Med Genet A. 2020;182:1496–9.
Allen HL, Flanagan SE, Shaw-Smith C, et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet. 2011;44:20–2.
Yorifuji T, Kawakita R, Hosokawa Y, et al. Dominantly inherited diabetes mellitus caused by GATA6 haploinsufficiency: variable intrafamilial presentation. J Med Genet. 2012;49:642–3.
Stanescu DE, Hughes N, Patel P, et al. A novel variant in GATA6 causes pancreatic agenesis. Pediatr Diabetes. 2015;16:67–70.
Škorić-Milosavljević D, Tjong FVY, Barc J, et al. GATA6 mutations: characterization of two novel patients and a comprehensive overview of the GATA6 genotypic and phenotypic spectrum. Am J Med Genet A. 2019;179:1836–45.
Garg V, Kathiriya IS, Barnes R, et al. GATA4 variants cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003;424:443–7.
Nemer G, Fadlalah F, Usta J, et al. A novel variant in the GATA4 gene in patients with tetralogy of Fallot. Hum Mutat. 2006;27:293–4.
Lien CL, Wu C, Mercer B, et al. Control of early cardiac-specific transcription of Nkx2-5 by a GATA-dependent enhancer. Development. 1999;126:75–84.
Durocher D, Charron F, Warren R, et al. The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. EMBO J. 1997;16:5687–96.
Charron F, Paradis P, Bronchain O, et al. Cooperative interaction between GATA-4 and GATA-6 regulates myocardial gene expression. Mol Cell Biol. 1999;19:4355–65.
Xin M, Davis CA, Molkentin JD, et al. A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc Natl Acad Sci U S A. 2006;103:11189–94.
Shiojima I, Komuro I, Inazawa J, et al. Assignment of cardiac homeobox gene CSX to human chromosome 5q34. Genomics. 1995;27:204–6.
Komuro I, Izumo S. Csx a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci U S A. 1993;90:8145–9.
Newman CS, Krieg PA. Tinman-related genes expressed during heart development in Xenopus. Dev Genet. 1998;22:230–8.
Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by variants in the transcription factor NKX2-5. Science. 1998;281:108–11.
McElhinney DB, Geiger E, Blinder J, et al. NKX2.5 variants in patients with congenital heart disease. J Am Coll Cardiol. 2003;42:1650–5.
Benson DW, Silberbach GM, Kavanaugh-McHugh A, et al. Variants in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest. 1999;104:1567–73.
Akçaboy MI, Cengiz FB, Inceoğlu B, et al. The effect of p.Arg25Cys alteration in NKX2-5 on conotruncal heart anomalies: variant or polymorphism? Pediatr Cardiol. 2008;29:126–9.
Heathcote K, Braybrook C, Abushaban L, et al. Common arterial trunk associated with a homeodomain variant of NKX2.6. Hum Mol Genet. 2005;14:585–93.
Ta-Shma A, El-Lahham N, Edvardson S, et al. Conotruncal malformations and absent thymus due to a deleterious NKX2-6 variant. J Med Genet. 2014;51:268–70.
Shaheen R, Al Hashem A, Alghamdi MH, et al. Positional mapping of PRKD1, NRP1 and PRDM1 as novel candidate disease genes in truncus arteriosus. J Med Genet. 2015;52:322–9.
Ta-Shma A, Khan TN, Vivante A, et al. Mutations in TMEM260 cause a pediatric neurodevelopmental, cardiac, and renal syndrome. Am J Hum Genet. 2017;100:666–75.
Pagnamenta AT, Jackson A, Perveen R, et al. Biallelic TMEM260 variants cause truncus arteriosus, with or without renal defects. Clin Genet Online ahead of print. 2021;101(1):127–33.
Inoue T, Takase R, Uchida K, et al. The c.1617del variant of TMEM260 is identified as the most frequent single gene determinant for Japanese patients with a specific type of congenital heart disease. J Hum Genet. 2024; in press.
Jin SC, Homsy J, Zaidi S, et al. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands. Nat Genet. 2017;49:1593–601.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Yamagishi, H. (2024). Human Genetics of Truncus Arteriosus. In: Rickert-Sperling, S., Kelly, R.G., Haas, N. (eds) Congenital Heart Diseases: The Broken Heart. Advances in Experimental Medicine and Biology, vol 1441. Springer, Cham. https://doi.org/10.1007/978-3-031-44087-8_51
Download citation
DOI: https://doi.org/10.1007/978-3-031-44087-8_51
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-44086-1
Online ISBN: 978-3-031-44087-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)